United-Guardian, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US9105711082
USD
5.94
0.17 (2.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

12.96 k

Shareholding (Mar 2025)

FII

0.59%

Held by 6 FIIs

DII

89.26%

Held by 10 DIIs

Promoter

0.00%

How big is United-Guardian, Inc.?

22-Jun-2025

As of Jun 18, United-Guardian, Inc. has a market capitalization of 37.53 million, with net sales of 11.41 million and a net profit of 2.89 million over the latest four quarters.

Market Cap: As of Jun 18, United-Guardian, Inc. has a market capitalization of 37.53 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, United-Guardian, Inc. reported net sales of 11.41 million and a net profit of 2.89 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 11.88 million and total assets of 14.23 million.

Read More

What does United-Guardian, Inc. do?

22-Jun-2025

United-Guardian, Inc. is a micro-cap company that manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, and specialty industrial products. As of March 2025, it reported net sales of $2 million and a net profit of $1 million, with a market cap of $37.53 million.

Overview:<BR>United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products, operating within the specialty chemicals industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 37.53 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 13.00 <BR>Dividend Yield: 8.57% <BR>Debt Equity: -0.75 <BR>Return on Equity: 26.64% <BR>Price to Book: 3.46<BR><BR>Contact Details:<BR>Address: 230 Marcus Blvd, HAUPPAUGE NY: 11788-3731 <BR>Tel: 1 631 2730900 <BR>Fax: 1 631 2730858 <BR>Website: http://www.u-g.com/index.php

Read More

Should I buy, sell or hold United-Guardian, Inc.?

22-Jun-2025

Who are in the management team of United-Guardian, Inc.?

22-Jun-2025

As of March 2022, the management team of United-Guardian, Inc. includes Mr. Kenneth Globus as Chairman, President, CEO, and General Counsel, along with independent directors Mr. Andrew Boccone, Mr. Arthur Dresner, Mr. Lawrence Maietta, and Mr. S. Ari Papoulias.

As of March 2022, the management team of United-Guardian, Inc. includes Mr. Kenneth Globus, who serves as the Chairman of the Board, President, Chief Executive Officer, and General Counsel. Additionally, the board features several independent directors: Mr. Andrew Boccone, Mr. Arthur Dresner, Mr. Lawrence Maietta, and Mr. S. Ari Papoulias.

Read More

Is United-Guardian, Inc. overvalued or undervalued?

20-Sep-2025

As of March 21, 2025, United-Guardian, Inc. is considered very attractive due to its undervalued P/E ratio of 13, strong growth potential indicated by a PEG ratio of 0.60, impressive ROCE of 119.03%, and a high dividend yield of 8.45%, despite a disappointing 1Y return of -45.42% compared to the S&P 500's 17.14%.

As of 21 March 2025, the valuation grade for United-Guardian, Inc. moved from fair to very attractive, indicating a significant improvement in its perceived value. The company appears undervalued, particularly given its P/E ratio of 13, which is lower than the peer average of 15.34, and a PEG ratio of 0.60, suggesting strong growth potential relative to its price. Additionally, the company boasts an impressive ROCE of 119.03% and a dividend yield of 8.45%, which further supports its attractive valuation.<BR><BR>In comparison to its peers, United-Guardian, Inc. stands out with a more favorable valuation profile, especially when contrasted with Rayonier Advanced Materials, Inc., which has a P/E of -1.04, and Gevo, Inc., which has a P/E of -8.19. Despite its attractive valuation metrics, the company's recent stock performance has been disappointing, with a 1Y return of -45.42% compared to the S&P 500's 17.14%, highlighting the disconnect between market perception and intrinsic value.

Read More

Is United-Guardian, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, United-Guardian, Inc. has shifted to a bearish trend with weak strength, indicated by bearish daily moving averages and a monthly MACD, while significantly underperforming the S&P 500 with year-to-date and one-year returns of -17.05% and -45.42%, respectively.

As of 12 September 2025, the technical trend for United-Guardian, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, as indicated by the daily moving averages being bearish and the monthly MACD also showing a bearish signal. The Bollinger Bands and KST confirm this bearish outlook on a monthly basis. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -17.05% compared to the S&P's 12.22%, and a one-year return of -45.42% versus 17.14% for the benchmark.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a fall in Net Sales of -0.48%, the company declared Very Negative results in Jun 25

  • NET PROFIT(HY) At USD 1.16 MM has Grown at -37.66%
  • OPERATING CASH FLOW(Y) Lowest at USD 2.12 MM
  • NET SALES(HY) At USD 5.32 MM has Grown at -19.95%
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 39 Million (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

7.10%

stock-summary
Debt Equity

-0.73

stock-summary
Return on Equity

22.07%

stock-summary
Price to Book

3.39

Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.65%
0%
-31.65%
6 Months
-27.12%
0%
-27.12%
1 Year
-39.33%
0%
-39.33%
2 Years
-26.36%
0%
-26.36%
3 Years
-48.03%
0%
-48.03%
4 Years
-60.88%
0%
-60.88%
5 Years
-58.75%
0%
-58.75%

United-Guardian, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.14%
EBIT Growth (5y)
-11.95%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.75
Sales to Capital Employed (avg)
1.03
Tax Ratio
20.93%
Dividend Payout Ratio
84.79%
Pledged Shares
0
Institutional Holding
23.95%
ROCE (avg)
139.51%
ROE (avg)
29.76%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
3.51
EV to EBIT
9.26
EV to EBITDA
8.99
EV to Capital Employed
11.02
EV to Sales
2.62
PEG Ratio
0.60
Dividend Yield
8.45%
ROCE (Latest)
119.03%
ROE (Latest)
26.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 8 Schemes (10.15%)

Foreign Institutions

Held by 6 Foreign Institutions (0.59%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 12.00% vs 0.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 20.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.80",
          "val2": "2.50",
          "chgp": "12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.60",
          "val2": "0.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "245.00%",
          "val2": "246.20%",
          "chgp": "-0.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.93% vs -14.17% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 26.92% vs 0.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.20",
          "val2": "10.90",
          "chgp": "11.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.70",
          "val2": "3.00",
          "chgp": "23.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.50",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.30",
          "val2": "2.60",
          "chgp": "26.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "299.40%",
          "val2": "263.00%",
          "chgp": "3.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
2.80
2.50
12.00%
Operating Profit (PBDIT) excl Other Income
0.70
0.60
16.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.60
0.60
Operating Profit Margin (Excl OI)
245.00%
246.20%
-0.12%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 12.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 20.00% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
12.20
10.90
11.93%
Operating Profit (PBDIT) excl Other Income
3.70
3.00
23.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.50
-100.00%
Consolidate Net Profit
3.30
2.60
26.92%
Operating Profit Margin (Excl OI)
299.40%
263.00%
3.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 11.93% vs -14.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 26.92% vs 0.00% in Dec 2023

stock-summaryCompany CV
About United-Guardian, Inc. stock-summary
stock-summary
United-Guardian, Inc.
Specialty Chemicals
United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The Company also conducts research and product development, primarily related to the development of cosmetic and personal care products. Its research and development department also modifies, refines, and expands the uses for existing products. Its products are separated into approximately four distinct product categories, such as personal care products (including cosmetic ingredients), pharmaceuticals, medical products and industrial products. Its personal care products are marketed globally by approximately six marketing partners. The products are sold directly to marketing partners, which in turn resell those products to its customers for use in the manufacture or compounding of the customers' personal care and cosmetic products.
Company Coordinates stock-summary
Company Details
230 Marcus Blvd , HAUPPAUGE NY : 11788-3731
Registrar Details